Read the story about Boehringer Ingelheim's first biotech facility in Asia , which is based on NNE’s Bio on demand™ concept for flexible facility design.
Beijing Fresenius Pharmaceutical needed to establish a new compliant pharma production facility. Read how NNE helped ensure full GMP compliance.
Read how NNE’s local biotech pharma know-how came in handy when we helped Novozymes build an industrial biotech plant for cost-effective enzyme production.
Read the story about NNE’s long-term commitment in the expansion of Sanofi Pasteur’s GMP manufacturing facility for vaccines in Shenzhen, China.
PT Widatra Bhakti built a new large volume parenterals facility based on NNE’s facility design. Read about the fast-track project.
Read why ZMC Ltd. chose NNE as its engineering partner for its first biotech manufacturing plant in China.
Read how our pharmaceutical plant design helped PT Widatra Bhakti meet its capacity problems and new authority requirements.
Read about the optimization of one of the world’s largest enzyme fermentation plants – Novozymes’ industrial biotechnology facility in Hongda, China.
NNE challenged Junshi to choose a modular facility design. Read how this lead to high flexibility in Junshi's large-scale biotech plant.
A strategically important project SHiP II is one of the initiatives in Roche’s 2018 master plan to develop its Shanghai site and the first fully integrated pharma hub in Asia Pacific.